HBIO

3.63% 0.0175

Handel nachbörslich: .50

Harvard Bioscience Inc (HBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1161)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HBIO Harvard Bioscience Inc	0.50	21.18M	106.79M	-8.73M	10.81M	-0.20
ISRG Intuitive Surgical Inc	482.35	169.15B	9.15B	2.61B	1.99B	7.17
BDX Becton Dickinson Co	195.96	55.18B	21.39B	1.59B	2.55B	5.56
RMD Resmed Inc	288.28	41.63B	5.15B	1.40B	1.65B	9.51
ALC Alcon Inc	86.48	41.88B	9.93B	1.12B	1.58B	2.25
WST West Pharmaceutical Services Inc	246.22	17.28B	2.90B	467.20M	306.90M	6.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2021-01-07	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2020-12-09	Eingeleitet	Northland Capital	Outperform
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2019-07-08	Herabstufung	Janney	Buy → Neutral
2018-01-24	Bestätigt	Janney	Buy
2018-01-23	Bestätigt	The Benchmark Company	Buy
2016-11-17	Eingeleitet	Singular Research	Buy
2015-07-28	Eingeleitet	The Benchmark Company	Buy

Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Vergleichen Sie HBIO mit anderen Aktien

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Harvard Bioscience enters retention agreement with interim CFO Mark Frost By Investing.com - Investing.com Nigeria

Harvard Bioscience Offers CFO $100K Retention Bonus - TipRanks

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2025 Earnings Call Transcript - Insider Monkey

Harvard Bioscience 2025 Q2 Earnings Narrows Losses with 22% Drop in Net Loss - AInvest

Harvard Bioscience Amends Credit Agreement with Lenders Amid Concerns Over Future Operations - AInvest

Is Now a Good Time to Reenter Harvard Bioscience Inc.Target Return Focused Trade Insights Shared - 선데이타임즈

Harvard Bioscience: Q2 Earnings Snapshot - Norwalk Hour

Harvard Bioscience Inc (HBIO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada

Harvard Bioscience Reports Q2 2025 Financial Results - TipRanks

Harvard Bioscience Q2 2025: Unpacking Contradictions in NIH Funding, Refinance Terms, and China Market Outlook - AInvest

Harvard Bioscience Amends Credit Agreement with Lenders - TipRanks

Harvard Bioscience Delivers Steady Results And Eyes Growth Ahead - Finimize

Harvard Bioscience Delivers Steady Results And Improved Cash Flow - Finimize

Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates - MSN

Harvard Bioscience Q2 2025 Earnings Call Transcript - MarketBeat

Harvard Bioscience: Navigating Debt and Innovation in the Biotech Tools Sector - AInvest

Harvard Bioscience sets Q3 revenue target at $19M-$21M, CEO outlines priorities for 2025. - AInvest

Harvard Bioscience earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Earnings call transcript: Harvard Bioscience Q2 2025 results show mixed signals - Investing.com Nigeria

Transcript : Harvard Bioscience, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener

Harvard Bioscience Q2 2025 slides: improved profitability despite revenue challenges - Investing.com Canada

Harvard Bioscience's Q2 2025 Performance: A Strategic Turnaround Amid Debt Refinancing Challenges - AInvest

Harvard Bioscience Reports Q2 Earnings Beat, Initiates Q3 Outlook - AInvest

Harvard Bioscience Tops Q2 Revenue Views - The Motley Fool

Harvard Bioscience Tops Q2 Revenue Views - The Globe and Mail

Harvard Bioscience Q2 revenue meet estimates - MarketScreener

Harvard Bioscience Q2 2025 Financial Results - TradingView

Harvard Bioscience Announces Second Quarter 2025 Financial Results - GlobeNewswire

Harvard Bioscience Q2 Earnings: Revenue Beats Guidance as New CEO Charts Turnaround Path - Stock Titan

Will Harvard Bioscience Inc. benefit from macro trendsFree High Conviction Intraday Stock Signals - Newser

Harvard Bioscience Inc. stock daily chart insights2-Day Signal Watch with Forecast Outcome - Newser

Harvard Bioscience Inc. stock outlook for YEARStock Entry Points Based on Technicals - Newser

Why Harvard Bioscience Inc. stock attracts strong analyst attentionFree Real Time Alerts Based on AI Prediction - Newser

Relative strength of Harvard Bioscience Inc. in sector analysisFree Alert Feed for Momentum Based Picks - Newser

What earnings revisions data tells us about Harvard Bioscience Inc.Free Weekly Potential Breakout Stock List - Newser

Is Harvard Bioscience Inc. stock poised for growthReal Chart Based Opportunity Identification - Newser

Real time scanner hits for Harvard Bioscience Inc. explainedFree Proven Entry Plan With Low Risk Trade - Newser

Harvard Bioscience HBIO 2025Q2 Earnings Preview Upside Anticipated on Innovative Gene Therapy Developments - AInvest

Harvard Bioscience Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView

Earnings To Watch: Harvard Bioscience Inc (HBIO) Reports Q2 2025 Result - Yahoo Finance

Chart overlay techniques for tracking Harvard Bioscience Inc.AI Intraday Market Movement Prediction Tool - Newser

Harvard Bioscience Enters Sixth Amendment To Credit Agreement; Lenders Agree Not To Test Financial Covenants For Q3 2025; Agrees To Pay $400K Fees To Lenders; Explores Alternative Capital Sources For Refinancing; Says There Is Substantial Doubt - 富途牛牛

Harvard Bioscience announces CEO succession plan - MSN

Harvard Bioscience Sets Q2 2025 Earnings Release and Conference Call - AInvest

Harvard Bioscience, Inc. to Release Q2 2025 Financial Results and Host Conference Call on August 11, 2025 - Quiver Quantitative

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET - GlobeNewswire

Harvard Bioscience Upcoming Q2 2025 Earnings: Pre-Market Release and Conference Call Details Revealed - Stock Titan

Published on: 2025-08-04 19:22:29 - beatles.ru

Using R and stats models for Harvard Bioscience Inc. forecastingFree Capital Growth With Controlled Risk Picks - Newser

Harvard Bioscience Inc. Stock Analysis and ForecastInvest confidently with professional market insights - Jammu Links News

What are analysts’ price targets for Harvard Bioscience Inc. in the next 12 monthsFree Trading Psychology Coaching - Jammu Links News

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HBIO